You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

 

Switch to US site
Covid-19 Resource Center
Select region
Submit
Menu
  • Products and Solutionsmore
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Servicesmore
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insightsmore
    • Articles
    • Events
    • Getinge Experience Center
    • Research funding requests

    • Insights main page →
  • Companymore
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • History
    • News
    • Legal Information
    • Instructions For Use/Patient Information
    • Product Catalog
    • COVID-19 Resource Center
    • Investors
    • Careers
  • Contact
  • Products and Solutions
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Services
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insights
    • Articles
    • Events
    • Getinge Experience Center
    • Research funding requests

    • Insights main page →
  • Company
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • History
  • Contact
  • Start
  • Insights
  • Articles
  • Operating Room
  • Low-flow anesthesia
  • Why low-flow anesthesia?
  • Low-flow anesthesia offers pulmonary, economic and environmental benefits
  • Should we change to low- or minimal-flow anesthesia?
  • Theory and practice of minimal fresh gas flow anesthesia
  • What are potential risks of low-flow anesthesia?

Low-flow anesthesia

Topic
Operating Room
Patient under anesthesia
Topic
Operating Room
Subscribe

Stay informed! Subscribe for the latest articles

Thank you for your interest in Getinge.

Why low-flow anesthesia?

Already in 1924 RM Waters published an article in Anesthesia and Analgesia where he presents improved economy, convenience and welfare of the patients as the benefits of using a re-breathing system during anesthesia [1]. This is still true today but we can also add welfare of the planet as another major benefit.

Low-flow anesthesia offers pulmonary, economic and environmental benefits

In low-flow anesthesia, a rebreathing system uses a fresh gas flow (FGF) that is less than the alveolar ventilation of the patient. This technique uses less anesthetic agents than conventional systems, emits less gas into the atmosphere, and improves the flow dynamics of the inhaled air. Low flow is generally characterized by a fresh gas flow of less than 1.0 L/min. In minimal flow, the FGF is decreased to 0.5 L/min.

Should we change to low- or minimal-flow anesthesia?

Reducing the fresh gas flow has several benefits:

web-anesthesia-low-flow-icon-economy-120x120.jpg

Economy

Agent expenditure accounts for a large part of the total cost of ownership of anesthesia machines. Reducing the anesthetic agent consumption in your ORs will have a positive impact on your overall hospital expenditure.

web-anesthesia-low-flow-environmental-120x120.jpg

Environmental impact

With low-flow anesthesia, a lower amount of anesthetic agent is released into the environment, reducing the impact of fluorocarbons and nitrous oxide on the ozone layer, thus reducing the overall greenhouse gas emissions.

web-anesthesia-low-flow-patient-safety-120x120.jpg

Patient comfort and safety

Low FGF improves the flow dynamics of inhaled gases, increases mucociliary clearance, maintains body temperature and reduces water loss. 

web-anesthesia-low-flow-staff-safety-120x120.jpg

OR staff safety

With less unused surplus gas discharged into the atmosphere, the concentration of anesthesia gas in the OR is greatly reduced. This minimizes occupational risk for OR staff.

Theory and practice of minimal fresh gas flow anesthesia

The review by Brattwall et al. in the Canadian Journal of Anesthesia, outlines the benefits of minimal fresh gas flow anesthesia.  It provides practical guidance on safe implementation of low- and minimal-flow anesthesia in routine clinical practice. [2]

What are potential risks of low-flow anesthesia?

Hypoxic mixtures

The formation of hypoxic mixtures are one of the greatest risk of using low-flow anesthesia. Reducing fresh gas flow in a rebreathing circle system results in a difference between the delivered O2 concentration(FD) at the common gas outlet and the inspired O2 (FIO2). Consequently, FIO2 becomes lower than the fraction of delivered oxygen (FDO2). This may not always be sufficiently recognized, and if settings are not adjusted, hypoxic mixtures can develop. An active inspired hypoxic guard has been shown to prevent the formation of hypoxic mixtures.

Learn how to avoid hypoxic mixtures

Inadequate depth of anesthesia

During low-flow anesthesia there is a potential risk for inadequate anesthetic gas concentration. An automatic gas control (AGC) system removes the need for continuous manual adjustments of FGF, FIO2 and EtAA. Targeting FIO2 directly will help avoid hypoxia. Targeting EtAA at the desired speed will reduce the risk of under- or overdosing.

Learn more about our Automatic Gas Control (AGC)

Related Articles

View all

The Value of Advanced Hemodynamic Monitoring

Beyond Basic - with advanced hemodynamic parameters. Learn more about blood pressure, blood flow, preload, afterload, contractility, and pulmonary edema parameters.

Operating Room
Intensive Care

Optimized sterile supply flow with T-DOC driven automation in the world’s most advanced CSSD

The Capital Region of Denmark decided to merge their seven CSSDs into one regional CSSD. It was clear that they needed a sterile supply management solution that could manage the entire flow: From logistics and warehousing to interfacing with multiple hospital IT systems and driving automation in the CSSD. And the choice fell on T-DOC.

Operating Room
Sterile reprocessing
Digital Health

At Klinikum Stuttgart efficient surgical planning is the key to success

OR management plays a key role for us at Klinikum Stuttgart. Torin, helps map all process steps to streamline workflows and optimize performance. This led to a 3.4% increase in surgeries in 2019, which is an additional 2,000 surgeries in a year.

Operating Room
Sterile reprocessing
Digital Health

All references

  1. 1. Waters R.M 1924 Clinical scope and utility of carbon dioxid filtration in inhalation anesthesia. Anesthesia and Analgesia Feb p 20-22, 26

  2. 2. Brattwall M, et al. Brief review: Theory and practice of minimal fresh gas flow anesthesia. Can J Anesth/J Can Anesth (2012) 59:785–797

You are browsing the international version of our website

You have landed on the International version of our website. Please note that the product offerings for the international market may differ from United States.

You can switch back to the US website at any time using the language and market selector at the bottom of the page or from he fold-out menu.

Ok!

You are now leaving Getinge.com. You might access content  not managed by Getinge team, in that case Getinge can not be hold responsible of the content. 

I understand! Stay in Getinge.com

Our offer

  • Products and Solutions
  • Services

Support and tools

  • Insights
  • COVID-19 Resource Center
  • Events
  • Past Webinars
  • Instructions For Use/Patient Information

Company

  • Investors
  • Careers
  • Corporate Governance
  • History
  • Legal Information
  • Website use disclaimer
  • Cookie Notice
Get in contact International (English)

This website is intended to provide information to an international audience outside of the US.
All images used are for illustrative purposes only and may not accurately represent the product or its use.

April 2022

© Copyright 2022 Getinge AB. All rights, including all intellectual property rights, reserved.

  • Products and Solutions
  • Services
  • Insights
  • Company
  • News
  • Legal Information
  • Instructions For Use/Patient Information
  • Product Catalog
  • COVID-19 Resource Center
  • Investors
  • Careers
  • Contact